🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

@Fibrobiologics’ CSO, Hamid Khoja, will be presenting on the potential treatment of chronic diseases by promoting immune system balance at The German-Nordic Joint Extracellular Matrix Meeting on March 27. For more: bit.ly/4hCstH2 $FBLG #RegenerativeMedicine

Missed FibroBiologics’ analyst day? A Q&A transcript with CSO Hamid Khoja, Ph.D., is now available, covering the latest science behind our fibroblast-based therapeutics. bit.ly/41KD9gW $FBLG #AnalystDay

🔬 #DYK our fibroblast therapy has the potential to reshape #MultipleSclerosis treatment for nearly 3 million people worldwide. See our pipeline: bit.ly/41HUoPZ #BiotechResearch #Innovation

Our CSO, Hamid Khoja caught up with Healio Dermatology as we prepare for our upcoming clinical trials in wound care. For more: bit.ly/4ce0gFr $FBLG #BiotechInnovation #RegenerativeMedicine

.FibroBiologics announces a scientific advancement in brain tissue repair—potentially opening new treatment paths for multiple sclerosis. For more: bit.ly/4le92r3 $FBLG #RegenerativeMedicine #MultipleSclerosis

.FibroBiologics has opened a new 10,000+ sq ft Houston lab to expand R&D and explore the potential for in-house GMP manufacturing. Learn more: bit.ly/4jqF5m0 $FBLG #ChronicDisease #CellTherapy #Innovation

.@Fibrobiologics’ CSO, Hamid Khoja, will be presenting on homeostasis restoring potential of our fibroblast-based cell therapy candidate at Alliance for Regenerative Medicine (ARM)’s #CGMed25 on April 16. For more: bit.ly/42wtuLg $FBLG #RegenerativeMedicine #CGMed25 #CellTherapy

@Fibrobiologics presented preclinical data at Society for Investigative Dermatology’s Annual Meeting showing potential of its HDF spheroids to reduce #psoriasis. Poster presented by Chuo Fang, M.D., Ph.D.: bit.ly/4jpTb6N $FBLG #CellTherapy

#Psoriasis affects approx. 3% of the U.S. population—7.5M people—impacting both physical & mental health. Our fibroblast-based approach targets immune dysregulation for a potential long-term solution. bit.ly/41HUoPZ

FibroBiologics has appointed Jason D. Davis, CPA, as #CFO. With over 20 years in healthcare finance, his leadership will support our work advancing fibroblast-based therapeutics into the clinic. Read more: bit.ly/4kJeocY #Leadership #FinanceFunction

Dr. Hamid Khoja of FibroBiologics joined a biotech roundtable hosted by BioProcess Online Cell&Gene where he shared his views on 3D cell manufacturing and the need for clearer definitions and safeguards around AI in life sciences. $FBLG #BiotechInnovation #CellTherapy

.FibroBiologics to present at BIO 2025. CEO Pete O’Heeron will share updates on potential fibroblast-based therapies for wound healing, MS, and psoriasis. 📅 June 17 | 10:45 AM ET | Room 154 More here: bit.ly/3TsJMR2 #BIO2025 #Biotech #ChronicDisease

FibroBiologics’ achievement of increased myelin expression in preclinical models was featured by Longevity Technology. For more: bit.ly/3SP86MM $FBLG #RegenerativeMedicine #MultipleSclerosis

Why does FibroBiologics use spheroids in its #fibroblast-based therapies? In this video, CSO Dr. Hamid Khoja explained how spheroids offer enhanced viability, do not require pre-culturing—all while potentially delivering stronger therapeutic impact than single cells. 🎥

#ICYMI: At #CGMed25, Dr. Hamid Khoja of FibroBiologics shared how fibroblast-based cell therapy may restore immune function in chronic inflammation-driven diseases. $FBLG #CellTherapy #BiotechInnovation #RegenerativeMedicine Alliance for Regenerative Medicine (ARM)

Dr. Hamid Khoja of FibroBiologics explains how topical fibroblast spheroids may promote both local and systemic immune effects—a promising advancement for cell therapy. 🎥 Watch the full presentation: bit.ly/4kIuL9U $FBLG #CellTherapy #BiotechInnovation

Pete O’Heeron, CEO of FibroBiologics, shares how living with chronic disease has shaped his biotech mission. Read his guest column in InnovationMap: bit.ly/43GnRfh #Biotech #Houston

.FibroBiologics has confirmed the ability to manufacture CybroCell™ for degenerative disc disease (DDD) and cartilage repair using its existing CYWC628 master cell bank. Read more: ir.fibrobiologics.com/news-events/pr… #CellTherapy #DegenerativeDiscDisease #CartilageRepair #Fibroblasts